Novel Microdevices develops cost-effective, portable, rapid, multiplexed, and easy-to-use PCR testing solutions for infectious diseases and other applications.

Novel Microdevices

Lab-quality, Clinically Actionable Results in Minutes Anywhere!

    Novel Dx detects the genetic material of pathogens using Nucleic Acid Amplification techniques. These are the same methods that are utilized in large reference laboratories
    Novel Dx delivers lab-quality results in under 30 minutes so patients can be tested and treated in the same visit

CARB-X

We are excited to announce that Novel Microdevices was awarded ~$1.4M from NIH RADx® Tech to Develop our Next-generation, High Performance, Point-of-Care RT-PCR Test for the detection of respiratory viruses Influenza-A, Influenza-B, RSV and COVID-19 from nasal swabs in 15 minutes. 

Thank you BioBuzz and Chris Frew for this nice article covering our recent funding from The National Institutes of Health RADx Tech program and TEDCO. https://lnkd.in/eCFGVSKi
#baltimorecity #funding #diagnostics #marylandbusiness #rapidtesting #infectiousdiseases #pointofcare #pcr 

https://lnkd.in/eBNDqFRx

On our way to Chicago to attend #ADLM2024!! 

Novel Microdevices Hamdi Joda Rohan Pais Andrea Pais

Great feature on Andrea Pais, CEO of Novel Microdevices in Baltimore.  Entrepreneur, singer/songwriter and one of our new generation of Woman CEO's in Maryland.

https://lnkd.in/eNvxH9HX

Visit https://thelaunchport.com/ for more News about The LaunchPort

#innovation #baltimore #medicaldevices
Maryland Department of Commerce Baltimore Business Journal Baltimore Development Corporation The Baltimore Sun Technical.ly TEDCO BioHealth Innovation, Inc. BioBuzz UpSurge Baltimore ETC (Emerging Technology Centers) bwtech@UMBC Research and Technology Park Early Charm Scheer Partners South Duvall | Commercial Real Estate Investments Baltimore Peninsula Maryland Tech Council

Congratulations to Andrea Pais, CEO of Novel Microdevices, on her recent feature in Scheer Partners. In the interview, Andrea discusses her journey as an inventor, singer, and woman CEO of a #Baltimore-based start-up specializing in superfast PCR diagnostics equipment and assays. Novel Microdevices operates its device engineering center within #LaunchPort and conducts assay development at #CityGarage, making it one of the first wet lab spaces to operate within LaunchPort Baltimore. 

Watch the full interview on YouTube: https://rb.gy/rzbkzc

#BaltimoreTogether #BuildFromStrength

Rahul, we are very excited to have to on board and are looking forward to growing together! Congratulations and welcome to the Novel Microdevices Family!!

Reflecting on an exhilarating and exhausting week at #JPM2024! 

The panels, events, networking parties, and 1-on-1 partnering sessions were nothing short of amazing. 

It was a pleasure meeting familiar faces from the DMV region, including the incredible Tien Wong, Ethel Rubin and Deborah Hemingway, PhD. The sense of community and collaboration was truly inspiring.

A special shoutout to NIH SEED for sponsoring Novel Microdevices. Your support has been instrumental in making this experience possible. 

Looking forward to carrying the momentum forward and turning these connections into meaningful collaborations. Here's to pushing boundaries and making a lasting impact! 

🚀 #biotechshowcase #biotechinnovation #jpm2024 #Networking #Innovation #Collaboration #HealthcareRevolution #womeninbusiness #dmv #startuplife

Learn how Novel Microdevices’ rapid point-of-care diagnostic provides fast, simple, and accurate results in less than 15 minutes. Learn more at https://lnkd.in/e5ueHR4d

 #sbir #sttr #Biotechshowcase

So excited to be heading to SF for JPM week! 

#jpm2024 #jpmorgan #healthcare #startuplife

We are delighted to express our heartfelt appreciation for the incredible contributions of three outstanding interns who have been an invaluable part of the Novel Microdevice's team for the past two semesters. 

Rahul Gondi: Your dedication and passion for streamlining manufacturing processes have not only left a lasting impact on our team but have also set a new standard for excellence. Your attention to detail and innovative approach have been instrumental in reaching milestones on time.

Anuradha Mansinghka: Your analytical prowess and problem-solving skills have been nothing short of impressive. Your commitment towards research has significantly contributed to the success of our team. Your positive attitude and adaptability have made you a pleasure to work with.

Soham S.: Your creativity and technical acumen have been a driving force behind many successful initiatives at Novel Microdevices. Your ability to think out of the box has not only showcased your talent but has also positively influenced the entire team.

As they transition from interns to the next phase of their careers, we have no doubt that Rahul, Anuradha, and Soham will continue to achieve great things. It has been a pleasure watching them grow and contribute to Novel's success.
Thank you, Rahul, Anuradha, and Soham, for your exceptional work and dedication. Wishing you all the best in your future endeavors. The doors of Novel are always open for you! Anuradha Mansinghka Soham S. Rahul Gondi #Kudos Keep up the #GreatWork!

Metric
Company Name	Novel Microdevices
Symbol
MSH ID	COM:NOVELDX
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices and Diagnostics
Country	US
Stage
Employee Count
Website	noveldx.com
LinkedIn	noveldx
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NOVE

COM:NOVELDX

Novel Microdevices

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue